ARA-290

Timing

A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.

1. 1

   1–2 Weeks

   Animal studies show measurable pain-related improvement beginning within the first days to weeks of a dosing course.

2. 2

   3–4 Weeks

   Continued improvement in nerve-related pain sensitivity is typically described through this window in available trial data.

3. 3

   5–7 Weeks

   Effects are generally reported as sustained during this period in the available research.

4. 4

   8–10 Weeks

   Limited human trial data extends meaningfully into this window; most available data reflects animal study timelines.

5. 5

   11–15 Weeks

   No well-established human timeline exists to reference at this stage.

6. 6

   16–20 Weeks

   Animal studies have shown pain-related benefits persisting out to 20 weeks after a limited dosing course, though human data at this duration is limited.

7. 7

   21–24 Weeks

   No well-established human timeline exists to reference at this stage.

⚠️ Research context only. This is not medical advice and results are not guaranteed.